KARA VEIT: Open Payments
NPI 1134340144 · FISHKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 56 payments from 12 companies in 2025. Trend: 2023 $859 · 2024 $1,253 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $204 |
| ABBVIE INC. | 14 | $170 |
| Janssen Biotech, Inc. | 9 | $167 |
| LEO Pharma Inc. | 6 | $121 |
| Galderma Laboratories, L.P. | 4 | $71 |
| PFIZER INC. | 3 | $59 |
| Lilly USA, LLC | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| MERZ NORTH AMERICA, INC. | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
Products named: Bimzelx, TREMFYA, SKYRIZI, ADBRY, DUPIXENT, CIBINQO, ANZUPGO, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
